Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
UNVR Stock Summary
In the News
Magnetar Financial LLC Reduces Stake in MedTech Acquisition Corp
On July 25, 2023, Magnetar Financial LLC (Trades, Portfolio), a renowned investment firm, reduced its stake in MedTech Acquisition Corp ( MTACU , Financial). This article provides an in-depth analysis of the transaction, the profiles of both the firm and the traded company, and the potential implications for value investors.
Univar (UNVR) Boosts Food Ingredients Portfolio With CFS Deal
The new agreement will enable Univar (UNVR) to bring CFS' products to market in a region where supply has historically been inadequate.
Univar (UNVR) Boosts Portfolio With Grace's SYLOID FP Silica
Univar Solutions (UNVR) and Grace reach an agreement to distribute SYLOID FP silica in Europe, giving customers in the majority of European countries access to this versatile excipient.
Why Is Univar (UNVR) Up 0.4% Since Last Earnings Report?
Univar (UNVR) reported earnings 30 days ago. What's next for the stock?
Univar (UNVR) Closes Buyout of Turkish Distributor Kale Kimya
This acquisition expands Univar's (UNVR) supplier and client relationships, improves portfolio, and expands services in the Life Sciences and Industrial Solutions verticals.
Univar Solutions (UNVR) Broadens Food Ingredients Portfolio
ICL and Univar Solutions (UNVR) are committed to enhancing sustainable food options. The firms are critical to the global food supply chain.
Univar's (UNVR) Earnings and Revenues Surpass Estimates in Q1
Univar's (UNVR) first-quarter sales fell around 7% year over year as lower demand more than offset the company's pricing discipline.
Univar (UNVR) Q1 Earnings and Revenues Beat Estimates
Univar (UNVR) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.07 per share a year ago.
12 Stocks That Offer Growth, Value, and Momentum
Why pick one factor or style of investing when you can have them all?
Univar (UNVR) Picked by Patcham as Sole US Distributor of PATcat
Patcham USA selects Univar (UNVR) as its exclusive distributor of PATcat metal catalysts in the United States.
UNVR Financial details
UNVR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 60.71 | 56.59 | 48.67 | 55.63 | 68.55 | |
Net income per share | 1.21 | -0.64 | 0.31 | 2.69 | 3.26 | |
Operating cash flow per share | 2.04 | 2.22 | 1.34 | 1.69 | 3.26 | |
Free cash flow per share | 1.37 | 1.47 | 0.68 | 1.05 | 2.35 | |
Cash per share | 0.86 | 2.01 | 2.28 | 1.47 | 2.3 | |
Book value per share | 8.38 | 10.56 | 10.56 | 13.38 | 14.9 | |
Tangible book value per share | -5.82 | -5.29 | -4.3 | -1.34 | 0.23 | |
Share holders equity per share | 8.38 | 10.56 | 10.56 | 13.38 | 14.9 | |
Interest debt per share | 17.69 | 17.44 | 16.24 | 13.81 | 15.37 | |
Market cap | 2.52B | 3.98B | 3.23B | 4.86B | 5.32B | |
Enterprise value | 4.78B | 6.36B | 5.48B | 6.87B | 7.4B | |
P/E ratio | 14.64 | -37.67 | 61.02 | 10.55 | 9.76 | |
Price to sales ratio | 0.29 | 0.43 | 0.39 | 0.51 | 0.46 | |
POCF ratio | 8.7 | 10.93 | 14.23 | 16.74 | 9.74 | |
PFCF ratio | 12.92 | 16.48 | 27.92 | 27.09 | 13.56 | |
P/B Ratio | 2.12 | 2.3 | 1.8 | 2.12 | 2.13 | |
PTB ratio | 2.12 | 2.3 | 1.8 | 2.12 | 2.13 | |
EV to sales | 0.55 | 0.69 | 0.66 | 0.72 | 0.65 | |
Enterprise value over EBITDA | 8.13 | 10.14 | 9.6 | 7.9 | 7.09 | |
EV to operating cash flow | 16.49 | 17.48 | 24.17 | 23.67 | 13.55 | |
EV to free cash flow | 24.48 | 26.35 | 47.44 | 38.31 | 18.86 | |
Earnings yield | 0.07 | -0.03 | 0.02 | 0.09 | 0.1 | |
Free cash flow yield | 0.08 | 0.06 | 0.04 | 0.04 | 0.07 | |
Debt to equity | 2 | 1.57 | 1.47 | 0.99 | 0.99 | |
Debt to assets | 0.45 | 0.42 | 0.42 | 0.33 | 0.35 | |
Net debt to EBITDA | 3.84 | 3.8 | 3.95 | 2.31 | 1.99 | |
Current ratio | 1.64 | 1.69 | 1.74 | 1.73 | 1.99 | |
Interest coverage | 2.86 | 2.8 | 2.46 | 6.57 | 7.77 | |
Income quality | 1.68 | -3.63 | 4.29 | 0.63 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.12 | 0.13 | 0.13 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.38 | 0.4 | 0.4 | 0.37 | 0.34 | |
Capex to operating cash flow | -0.33 | -0.34 | -0.49 | -0.38 | -0.28 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.53 | -0.57 | -0.5 | -0.55 | -0.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.12 | 12.36 | 8.6 | 28.44 | 33.05 | |
ROIC | 0.08 | 8.46 | 0.05 | 0.11 | 0.11 | |
Return on tangible assets | 0.05 | -0.03 | 0.01 | 0.11 | 0.12 | |
Graham Net | -19.24 | -19.28 | -17.13 | -15.25 | -15.41 | |
Working capital | 854.1M | 1B | 1.04B | 1.22B | 1.6B | |
Tangible asset value | -827.1M | -868.2M | -730M | -229.6M | 39M | |
Net current asset value | -1.89B | -2.31B | -2.11B | -1.59B | -1.42B | |
Invested capital | 2 | 1.57 | 1.47 | 0.99 | 0.99 | |
Average receivables | 1.08B | 1.13B | 1.2B | 1.39B | 1.51B | |
Average payables | 933.55M | 910.2M | 830.05M | 887.2M | 995.9M | |
Average inventory | 821.4M | 799.65M | 735M | 803.1M | 1.04B | |
Days sales outstanding | 46.29 | 45.6 | 54.75 | 58.93 | 47.39 | |
Days payables outstanding | 50.17 | 45.71 | 44.59 | 51.58 | 41.2 | |
Days of inventory on hand | 43.55 | 40.66 | 39.28 | 47.64 | 47.71 | |
Receivables turnover | 7.89 | 8.01 | 6.67 | 6.19 | 7.7 | |
Payables turnover | 7.28 | 7.98 | 8.19 | 7.08 | 8.86 | |
Inventory turnover | 8.38 | 8.98 | 9.29 | 7.66 | 7.65 | |
ROE | 0.14 | -0.06 | 0.03 | 0.2 | 0.22 | |
Capex per share | -0.67 | -0.75 | -0.66 | -0.65 | -0.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 17.78 | 17.84 | 16.08 | 16.81 | 16.14 | |
Net income per share | 0.96 | 0.78 | 0.44 | 0.52 | 0.55 | |
Operating cash flow per share | 0.28 | 1.54 | 2.33 | -0.02 | 1.72 | |
Free cash flow per share | 0.09 | 1.3 | 2.02 | -0.26 | 1.51 | |
Cash per share | 1.38 | 1.65 | 2.39 | 2.37 | 2.69 | |
Book value per share | 15.2 | 15.34 | 15.47 | 16.23 | 17.15 | |
Tangible book value per share | 0.51 | 0.66 | 0.24 | 0.84 | 1.12 | |
Share holders equity per share | 15.2 | 15.34 | 15.47 | 16.23 | 17.15 | |
Interest debt per share | 15.03 | 15.14 | 15.5 | 16.06 | 15.62 | |
Market cap | 4.22B | 3.8B | 5.13B | 5.59B | 5.72B | |
Enterprise value | 6.51B | 6.03B | 7.21B | 7.75B | 7.74B | |
P/E ratio | 6.48 | 7.31 | 17.9 | 16.83 | 16.28 | |
Price to sales ratio | 1.4 | 1.27 | 1.98 | 2.08 | 2.22 | |
POCF ratio | 87.56 | 14.79 | 13.65 | -1.93K | 20.85 | |
PFCF ratio | 265.44 | 17.43 | 15.75 | -133.2 | 23.7 | |
P/B Ratio | 1.64 | 1.48 | 2.06 | 2.16 | 2.09 | |
PTB ratio | 1.64 | 1.48 | 2.06 | 2.16 | 2.09 | |
EV to sales | 2.16 | 2.02 | 2.78 | 2.89 | 3.01 | |
Enterprise value over EBITDA | 22.49 | 23.36 | 37.87 | 37.89 | 35.94 | |
EV to operating cash flow | 135.1 | 23.46 | 19.19 | -2.67K | 28.25 | |
EV to free cash flow | 409.55 | 27.65 | 22.14 | -184.5 | 32.11 | |
Earnings yield | 0.04 | 0.03 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | 0 | 0.06 | 0.06 | -0.01 | 0.04 | |
Debt to equity | 0.98 | 0.98 | 0.99 | 0.98 | 0.9 | |
Debt to assets | 0.34 | 0.34 | 0.35 | 0.35 | 0.34 | |
Net debt to EBITDA | 7.91 | 8.63 | 10.93 | 10.54 | 9.41 | |
Current ratio | 2.04 | 2.07 | 1.99 | 2.18 | 2.18 | |
Interest coverage | 9.96 | 7.57 | 3.71 | 4.4 | 4.82 | |
Income quality | 0.3 | 1.98 | 5.25 | -0.03 | 3.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.11 | 0.12 | 0.12 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.34 | 0.34 | 0.34 | 0.34 | 0.35 | |
Capex to operating cash flow | -0.67 | -0.15 | -0.13 | 13.48 | -0.12 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | |
Capex to depreciation | -0.73 | -0.87 | -1.08 | -0.9 | -0.72 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.12 | 16.38 | 12.44 | 13.78 | 14.58 | |
ROIC | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Return on tangible assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Graham Net | -15.27 | -15.22 | -16 | -15.61 | -15.44 | |
Working capital | 1.77B | 1.75B | 1.6B | 1.76B | 1.71B | |
Tangible asset value | 87.3M | 110M | 39M | 134.6M | 179.2M | |
Net current asset value | -1.31B | -1.32B | -1.42B | -1.35B | -1.35B | |
Invested capital | 0.98 | 0.98 | 0.99 | 0.98 | 0.9 | |
Average receivables | 1.82B | 1.78B | 1.61B | 1.53B | 1.54B | |
Average payables | 1.15B | 1.09B | 1.01B | 975.25M | 941.2M | |
Average inventory | 1.16B | 1.19B | 1.15B | 1.12B | 1.04B | |
Days sales outstanding | 54.44 | 52.29 | 51.72 | 52.89 | 52.49 | |
Days payables outstanding | 45.2 | 41.19 | 44.37 | 42.59 | 42.22 | |
Days of inventory on hand | 47.58 | 46.06 | 51.38 | 48.15 | 45.93 | |
Receivables turnover | 1.65 | 1.72 | 1.74 | 1.7 | 1.71 | |
Payables turnover | 1.99 | 2.18 | 2.03 | 2.11 | 2.13 | |
Inventory turnover | 1.89 | 1.95 | 1.75 | 1.87 | 1.96 | |
ROE | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | |
Capex per share | -0.19 | -0.23 | -0.31 | -0.24 | -0.21 |
UNVR Frequently Asked Questions
What is Univar Solutions Inc. stock symbol ?
Univar Solutions Inc. is a US stock , located in Downers grove of Il and trading under the symbol UNVR
What is Univar Solutions Inc. stock quote today ?
Univar Solutions Inc. stock price is $- today.
Is Univar Solutions Inc. stock public?
Yes, Univar Solutions Inc. is a publicly traded company.